ATLASCG Oncology (CGON) earnings date: Nov 13, 2026
CG Oncology (CGON) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.86.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CGON
| Last price | $64.68 (+1.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the CG Oncology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
CG Oncology reports on Nov 13, 2026. One email the day before, with ATLAS’s read on CG Oncology. You can switch it off at any time.
Alert me before CGON reportsFree to start. Creating an account takes under a minute.
CGON earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.86 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +7.2% |
| Average move around a report | ±4.4% (last 5) |
| Sector | Healthcare · Biotechnology |
CG Oncology earnings history: last 5 reports
CG Oncology last reported on Aug 6, 2026: EPS of -$0.90 against an estimate of -$0.64 (-40.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.64 | -$0.90 | -40.6% | Miss | +3.7% |
| Jun 24, 2026 | $0.15 | $0.27 | +80.0% | Beat | +10.8% |
| May 8, 2026 | -$0.54 | -$0.71 | -31.5% | Miss | +0.2% |
| Feb 27, 2026 | -$0.58 | -$0.51 | +12.1% | Beat | +2.9% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -4.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CGON
See the fair value, the probability range and the earnings history of CG Oncology on its ATLAS page.
CG Oncology (CGON) stock analysisPlans from €3.99 a month.
CG Oncology earnings: frequently asked questions
When does CG Oncology (CGON) report earnings?
CG Oncology is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CGON?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.86 per share (USD). Estimates can change before the report.
How often does CGON beat earnings estimates?
Of its last 5 reports with a recorded result, CG Oncology beat the EPS estimate 3 times; the average surprise was +7.2%. Past results do not predict the next one.
How much does CGON move around earnings?
Over its last 5 reports the stock moved an average of 4.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did CG Oncology beat earnings estimates last quarter?
CG Oncology last reported on Aug 6, 2026: EPS of -$0.90 against an estimate of -$0.64 (-40.6% surprise), a miss.
How much does CGON usually move in a day?
On a normal trading day the ATLAS model puts CGON’s one-day range at about ±2.5%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
- Mitsubishi UFJ Financial Group (MUFG) earnings date
- Mizuho Financial Group (MFG) earnings date
- KB Financial Group (KB) earnings date
- Twenty One Capital (XXI) earnings date
- LG Display Co. (LPL) earnings date
- Perpetua Resources (PPTA) earnings date
- Sinda (SIND) earnings date
- Americas Gold and Silver (USAS) earnings date
Educational information, not investment advice. Disclaimer